share_log

VistaGen Therapeutics | 8-K: Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update

SEC ·  Aug 14 04:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more